---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-003890"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T18:11:47.205864+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Health issues $4.6M convertible notes & warrants to existing note holders; no cash proceeds

## Summary
- Issued $4.6M principal amount of Future Advance Convertible Promissory Notes at 15% interest, convertible at $0.04/share, to prior ABL note holders.
- Issued Warrants to purchase 113.9M shares at $0.067 and 113.9M shares at $0.04, exercisable for 5 years.
- No cash proceeds; notes and warrants exchanged for prior $4.6M ABL notes issued July 2023 at 33% OID.
- Entered subordination agreement with NH Expansion Credit Fund Holdings LP; North Haven holds senior rights.
- Waiver letter postpones obligations for reverse stock split, share reserve, and registration statement filing through Dec 31, 2024.

## SEC filing metadata
- accession: 0001140361-24-003890
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036124003890/0001140361-24-003890-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036124003890/ny20018318x4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-003890
- JSON: https://secwatch.observer/filing/0001140361-24-003890.json
- Plain text: https://secwatch.observer/filing/0001140361-24-003890.txt

## Key facts
- Material Agreements
  SANUWAVE Health, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at aggregate principal amount of approximately $4.6 million (effective 2024-01-21).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited investors
  - Value: aggregate principal amount of approximately $4.6 million
  - Effective: 2024-01-21
  source text: On January 21, 2024, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”), with the Purchasers for the sale by the Company in a private placement (the “January Private Placement”) of (i) the Company’s Future Advance Convertible Promissory Notes in an aggregate principal amount of approximately $4.6 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036124003890/0001140361-24-003890-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.